We are live on ! Find out more
RC

Rangeley Capital Portfolio holdings

AUM $103M
1-Year Est. Return 77.32%
This Fund
S&P 500
This Quarter Est. Return
-9.22%
1 Year Est. Return
+77.32%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$93.4M
AUM Growth
-$18M
Cap. Flow
-$1.42M
Cap. Flow %
-1.52%
Top 10 Hldgs %
47.34%
Holding
111
New
29
Increased
12
Reduced
26
Closed
34

Top Buys

Rank Stock Value
1
ARVN icon
Arvinas
ARVN
+$8.51M
2
KROS icon
Keros Therapeutics
KROS
+$4.74M
3
SAGE
Sage Therapeutics
SAGE
+$2.82M
4
SGRY icon
Surgery Partners
SGRY
+$2.15M
5
SWTX
SpringWorks Therapeutics
SWTX
+$1.54M

Top Sells

Rank Stock Value
1
DRDBU
Roman DBDR Acquisition Corp II Unit
DRDBU
+$2.17M
2
NLOP
Net Lease Office Properties
NLOP
+$1.8M
3
SMC
Summit Midstream
SMC
+$1.72M
4
BUR icon
Burford Capital
BUR
+$1.54M
5
TH icon
Target Hospitality
TH
+$1.39M

Sector Composition

Rank Sector Weight
1 Healthcare 28.65%
2 Energy 16.07%
3 Consumer Discretionary 9.66%
4 Real Estate 9.29%
5 Materials 9.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OACCU
101
Oaktree Acquisition Corp III Life Sciences Unit
OACCU
– –
-10,000
Closed -$101K
GSRTU
102
DELISTED
GSR III Acquisition Corp Unit
GSRTU
– –
-20,133
Closed -$202K
MRLN
103
Merlin Inc
MRLN
$361M
– –
-11,800
Closed -$119K
DRDBU
104
Roman DBDR Acquisition Corp II Unit
DRDBU
– –
-217,800
Closed -$2.17M
MLACU
105
DELISTED
Mountain Lake Acquisition Corp Units
MLACU
– –
-95,000
Closed -$953K
VOXX
106
DELISTED
VOXX International Corporation Class A
VOXX
– –
-35,600
Closed -$263K
RVNC
107
CALL
DELISTED
Revance Therapeutics, Inc.
RVNC
– –
-110,000
Closed -$334K
CDMO
108
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
– –
-102,000
Closed -$1.26M
PSTX
109
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
– –
-97,300
Closed -$934K
LUNA
110
CALL
DELISTED
Luna Innovations Incorporated
LUNA
– –
-2,000
Closed -$4.32K
LUNA
111
DELISTED
Luna Innovations Incorporated
LUNA
– –
-23,000
Closed -$49.7K
1 2 3 4
5

Similar funds

EFT
Envision Financial Transparency Greensboro, North Carolina $103M AUM
GWL
Generations Wealth LLC Mason, Ohio $103M AUM
CC
Caspian Capital New York $103M AUM
ABLA
Alan B. Lancz & Associates Toledo, Ohio $103M AUM 31.99% 1-Year Est. Return
SPCM
Stoic Point Capital Management Palo Alto, California $103M AUM
OPAM
Olympus Peak Asset Management Greenwich, Connecticut $103M AUM 58.06% 1-Year Est. Return
ES
ETF Store Overland Park, Kansas $103M AUM 15.78% 1-Year Est. Return
IMT
Investment Management Trust Fitchburg, Massachusetts $103M AUM

Rangeley Capital's Q1 2025 Portfolio in Review

As of Q1 2025, Rangeley Capital held 111 positions worth $93.4M, down 16% from $111M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Rangeley Capital's Q1 2025 filing shows 29 new, 12 increased, 26 reduced and 34 closed positions. Its largest new stake was Arvinas: 543,000 shares worth $3.81M. The largest sale was Roman DBDR Acquisition Corp II Unit, an estimated $2.17M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 13% a quarter earlier, followed by Energy and Consumer Discretionary.

  • Rangeley Capital's largest Q1 2025 buy was Arvinas: 543,000 shares worth $3.81M.
  • Rangeley Capital added most to Jack in the Box in Q1 2025, an estimated $607K increase.
  • Rangeley Capital's biggest Q1 2025 reduction was Net Lease Office Properties, cutting an estimated $1.8M.
  • Rangeley Capital fully exited Roman DBDR Acquisition Corp II Unit in Q1 2025, selling an estimated $2.17M.
  • Rangeley Capital's ten largest holdings make up 47% of its $93.4M portfolio in Q1 2025.
  • Rangeley Capital opened 29 new positions and closed 34 in Q1 2025.
  • Rangeley Capital's portfolio value fell 16% quarter-over-quarter to $93.4M.

Based on Rangeley Capital's 13F filing for Q1 2025, filed 14 May 2025.